文献速递乳房整形与再造显微修复重建

围手术期COVID-19阳性患者即刻自体游离组织乳房再造:一例报告说明术后护理可行性

Breast reconstruction with immediate autologous free tissue transfer in a peri-operative COVID-19 positive patient: A case report illustrating feasibility of aftercare.
PubMed 文献 · J Plast Reconstr Aesthet Surg · 2020-11-07

本文报告一例2020年3月接受双侧乳房再造(DIEP和SIEP皮瓣)的患者,术后第3天出现症状并确诊COVID-19,通过远程医疗管理引流和敷料,术后2周在急诊COVID-19阳性区半择期引流乳房血清肿,共就诊换药门诊2次,3周愈合。尽管接受复杂手术和术前化疗,患者仅出现轻度上呼吸道症状,生理过程与正常术后无显著差异,表明远程医疗可用于管理自体乳房再造患者。

要点

  • COVID-19阳性患者接受自体游离皮瓣乳房再造后,可通过远程医疗管理引流和敷料。
  • 术后血清肿可在COVID-19阳性区域半择期引流,换药门诊就诊次数少。
  • 患者仅表现轻度上呼吸道症状,生理过程与正常术后无显著差异。

核心结论

  • 围手术期COVID-19阳性患者接受自体游离组织乳房再造后,可通过远程医疗管理术后护理,且未出现明显不良结局。

研究设计与样本

  • 个案报告:2020年3月一例双侧乳房再造(DIEP和SIEP皮瓣)患者,术后第3天确诊COVID-19。

主要发现

  • 患者术后第3天出现症状,COVID-19检测阳性后出院回家。
  • 通过远程医疗继续管理引流和敷料,术后2周形成乳房血清肿并在急诊COVID-19阳性区半择期引流。
  • 患者共就诊换药门诊2次,术后3周愈合。
  • 尽管接受复杂手术和术前化疗,患者仅出现轻度上呼吸道症状,生理上与正常术后无显著差异。

临床怎么用

  • 对于围手术期COVID-19阳性的自体乳房再造患者,可考虑使用远程医疗进行术后引流和敷料管理。
  • 术后血清肿可在COVID-19阳性区域半择期处理,减少普通门诊暴露。

局限性

  • 本文为单例个案报告,结论的普遍适用性有限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Globally, there has been a measured response to rationalise elective operating during the Coronavirus disease 2019 (COVID-19) pandemic. In terms of breast cancer care, this has led to a restricted provision of reconstruction with autologous free tissue transfer. A primary concern is the risk of mortality in elective surgery patients who develop COVID-19. The aim of this report is to describe the observed physiological impact of the virus on our patient, and to address how outpatient care after autologous free tissue transfer can be delivered to COVID-19 positive patients. In March 2020, we performed a bilateral breast reconstruction with a deep inferior epigastric perforator flap and a superficial inferior epigastric perforator flap. The patient became symptomatic on day three post-operatively, tested positive for COVID-19 and was discharged home. Drain and dressing management was continued through the use of telemedicine. Two weeks following the operation, a breast seroma formed that was drained semi-electively in the COVID-19 positive area of the Emergency Department. The patient visited the dressing clinic twice in total and healed after three weeks. Despite undergoing complex surgery and having pre-operative chemotherapy, our patient suffered a mild form of the virus limited to upper respiratory symptoms. Physiologically we did not see any significant difference to that of the normal post-operative course. This case demonstrates the possibility of managing autologous breast reconstruction patients using telemedicine. Although COVID-19 can complicate, or even be fatal, in the perioperative course, our patient thankfully suffered no discernable negative outcome from her infection.

来源:J Plast Reconstr Aesthet Surg,查看原文。版权归原作者所有。

引用

  1. Sharp O, Masud D. Breast reconstruction with immediate autologous free tissue transfer in a peri-operative COVID-19 positive patient: A case report illustrating feasibility of aftercare. J Plast Reconstr Aesthet Surg. 2020. PMID: 33214114. doi:10.1016/j.bjps.2020.10.088

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。